🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis? thelancet.com/journals/lanre… Learning about the individual risk for #CAPA development will allow for a more individualized #COVID19 management Martin Hoenigl🇺🇦🇦🇹 The Lancet Respiratory Medicine

CAPA in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis Posaconazole ⬇️CAPA incidence rate at our center. Future trials will focus on a more nuanced, risk-factors based prophylactic approach. Martin Hoenigl🇺🇦🇦🇹 @reisinger_alex link.springer.com/article/10.100…

YECMM is planning a 🍄 get-together during #ECCMID2024 ! Are you a young clinician/scientist interested in mycology ? Join us on Sunday 28/04. 👉 RSVP : forms.gle/mMd8WLAcAYDBjt… [Form to register will be sent shortly to those who RSVP and are interested to join YECMM]

#ÖGMM-Symposium zu invasive Mykosen am 09.04.24🍄im Hotel Brandlhof. Ab 13:30h (fast) alles Wissenswerte über Pilzinfektionen --> Keine Registrierung, keine Gebühren. Einfach teilnehmen 🥳🧐 Martin Hoenigl🇺🇦🇦🇹 Robert Krause und viele weitere Expert:innen! oegmm.at/wp-content/upl…

Are you under 40 years of age and want to be part of an international program in your early career in mycology? ➡️Join YoungECMM and enjoy its benefits 🔗Apllication form congresscare.eventsair.com/yecmm-fellows-… 🍄Further info on ecmm.info/yecmm/ Looking forward to connect and thrive 💫

🔥📰from CMR: Novel antifungals and Tx approaches to tackle resistance and improve outcomes of invasive fungal disease ASM CDC George Thompson Agostinho Carvalho Matthias Egger Simon Feys JP Gangneux Robert Krause Katrien Lagrou Jürgen Prattes journals.asm.org/doi/10.1128/cm…

Our #ECCMID2024 get-together will take place at 🚩Alice Secret Garden g.co/kgs/gBmxzD8 📋RSVP still online forms.gle/mMd8WLAcAYDBjt… See you 🍄

Most patients with sepsis don't need anti-anaerobic antibiotics. But most get them anyway. Why not, what's the harm? I worry the harm is considerable. Our new study in JAMA Internal Medicine: using a 15-month pip-tazo shortage to answer this question. 1/n jamanetwork.com/journals/jamai…

🍄Antifungal prophylaxis of #COVID19 associated pulmonary aspergillosis in pts on MV. Significant variation in CAPA incidence among centers not using prophylaxis (lower or significantly higher) vs center providing prophylaxis despite similar diagnostics. 🖇️bit.ly/3RWl8rR

Posa prophylaxis to prevent CAPA? Yes for centers with high-baseline CAPA rates and targeted in high-risk patients (e.g. EORTC risk factors present), no for others. rdcu.be/dNhzJ Martin Hoenigl🇺🇦🇦🇹 D.R. Giacobbe Matteo Bassetti JP Gangneux

Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients Simon Feys Agostinho Carvalho Neil Clancy JP Gangneux Katrien Lagrou Bart Rijnders authors.elsevier.com/c/1jR6n7tFB1Xh…

Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid Sarah Sedik Jürgen Prattes Matthias Egger SpringerMicrobiology link.springer.com/10.1007/s11046…

My interview for austrian national television on attributable mortality of candidemia and the ECMMCandida III study. Great study Jon Salmanton-García 🔎🍄🩸💉🦠 Philipp Koehler Oliver Cornely and others! ECMM Med Uni Graz on.orf.at/video/14235715…

Along w/ ECMM, we are seeking public comments on revised clinical outcome criteria for aspergillosis & other mold infections until 11/30 Draft: bit.ly/3YSopvX Supplement: bit.ly/3YXtCSn PW: ECMMMSGERCNov2024asp 📧comments to [email protected]

Proud of the results of a fantastic collaboration with MSGERC We invite all our followers and members to review and comment on the revised clinical outcome criteria on aspergillosis and other molds.

👉Participate in ECMM Candida IV 🌎wide study on candidemia caused by non-albicans Candida spp. Requirement: clinical data & isolate (not req for C.auris) Reward: Reimbursement & Authorship Observation period: 04/2024 - 09/2025 Interested? 📧 [email protected]

Posaconazole for Prevention of COVID‐19‐Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients: A European Multicentre Case–Control Study Jürgen Prattes D.R. Giacobbe JP Gangneux Matteo Bassetti florian reizine philipp eller Robert Krause onlinelibrary.wiley.com/doi/full/10.11…

Fully packed 2nd symposium of the austrian society of medical mycology (ÖGMM) - thanks to all speakers and participants for the interactive sessions

Join our Global ECMM Candida IV Study 🍄 ECMM ECMM Candida IV Martin Hoenigl🇺🇦🇦🇹 Stella Wolfgruber #ESCMIDGlobal2025

First retreat of our translational mycology working group 🍄👨🏼‍💻👩‍💻 Shaping future research topics and study designs in medical mycology 🦾 Martin Hoenigl🇺🇦🇦🇹 Sarah Sedik Stella Wolfgruber